... years, a third of the pharma market is going to be cell and gene therapies. Samarth Kulkarni, CEO CRISPR Therapeutics Piper Sandler Dec 2, 2020 ...
Source link
... years, a third of the pharma market is going to be cell and gene therapies. Samarth Kulkarni, CEO CRISPR Therapeutics Piper Sandler Dec 2, 2020 ...
Source link